Osborn Williams & Donohoe’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,800
Closed -$17K 702
2019
Q1
$17K Buy
+2,800
New +$17K ﹤0.01% 576